AJR Live Webinars feature leading experts discussing some of AJR’s most controversial, cutting-edge articles—broadcasted each month live, online, with CME.

Miss a broadcast? You can still watch past webinars and earn credit.

Past AJR Live Webinars

The AJR Live Webinar Series was made possible in part by an unrestricted educational grant from Siemens Healthcare.

Upcoming Webinars

Whole-Body MRI and Cancer Predisposition Syndromes in Children and Adults 

April 14, 2021

Broadcasted Live and Online 12:00 noon–1:00 pm, Eastern Time 
Moderator: Jonathan R. Dillman, MD, MSc
Speakers: Michael S. Gee, MD, Mary-Louise Greer, MD

REGISTER NOW

This AJR Live Webinar offers 1 CME Credit.

ARRS Member Price: $0

ARRS In-Training Member Price: $0 
Nonmember Price: $99

This webinar will review the use of whole-body MRI for the evaluation of children and adults with cancer predisposition syndromes. Indications, performance, and interpretation will be discussed. Available literature will be presented also.   

Learning Outcomes

After attending this session, participants will be able to:

  • Describe state-of-the-art whole-body MRI techniques for evaluating children and adults with cancer predisposition syndromes.
  • List common cancer predisposition syndromes for which whole-body MRI is indicated.
  • Recognize common key imaging findings in common cancer predisposition syndromes.

In-Bore and Fusion MRI-guided Biopsy of PI-RADS Category 4 and 5 Lesions

May 19, 2021

Broadcasted Live and Online 12:00 noon–1:00 pm, Eastern Time 
Moderator: Nicola Schieda, M.D.
Speakers: Fergus Coakley, M.B. B.Ch

REGISTER NOW

This AJR Live Webinar offers 1 CME Credit.

ARRS Member Price: $0

ARRS In-Training Member Price: $0 
Nonmember Price: $99

This webinar will review an original research article which compares in-bore to fusion biopsy in PI-RADS category 4 and 5 lesions at a single-center with propensity scoring. A discussion of the value of in-bore biopsy to fusion biopsy for prostate cancer diagnosis will help to better understand this complex topic.

Learning Outcomes

After attending this session, participants will be able to:

  • Describe the differences between in-bore and fusion-ultrasound-MRI guided biopsy strategies for diagnosis of prostate cancer in PI-RADS category 4 and 5 lesions.
  • Explain the potential advantages and potential disadvantages of in-bore versus fusion-ultrasound-MRI guided biopsy strategies for diagnosis of prostate cancer in PI-RADS category 4 and 5 lesions.
  • Report the potential incremental benefit of in-bore MRI guided targeted biopsy compared to fusion-lltrasound-MRI guided biopsy of prostate lesions detected on MRI.

The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

The ARRS designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.